Alberto Santagostino

Lonza AG
Senior Vice President, Head of Cell & Gene Technologies.
Alberto is Head of the Cell and Gene Technologies Business Unit at Lonza Pharma & Biotech, the leading global CDMO with a prominent presence in new modalities. Together with his team, Alberto’s objective is to serve customers by taking their products through the technical CMC journey to commercialization and industrial scale manufacturing.

Before joining Lonza Pharma & Biotech, Alberto was a Partner at McKinsey & Company, accruing 12 years of experience working closely with established industry leaders and emerging players. Alberto led the Biotechnology service line, as well as the Pharmaceutical and Medical Product practice, and has a deep knowledge of the manufacturing challenges faced by companies in the biopharma space.

Alberto is passionate about biotechnology - the science and the business